Comparison of renal toxicities with LY231514 600mg/m² versus 500mg/m² in the treatment of stage III or -IV cervical cancer / A. Carstens
Cervical cancer is the most common cancer diagnosed in females in South Africa and constitutes 16.47% of all cancers registered. LY231514, a new multi-targeted antifolate, is a potent in vitro inhibitor of thyrnidylate synthase (TS), dihydrofolate reductase (DHFR) and glycinamide ribonucleotide form...
| Main Author: | |
|---|---|
| Published: |
Potchefstroom University for Christian Higher Education
2009
|
| Online Access: | http://hdl.handle.net/10394/1600 |